表 2. Comparison of the therapeutic indicators of the three different endoscopic therapies.

3组不同治疗方式的治疗指标比较

Item	Group 1 (n=22)	Group 2 (n=30)	Group 3 (n=21)	χ2/H	P
Group 1, Group 2, Group 3: Denotes the same as those in table 1. * One case with liver cancer and portal thrombosis in group 2 and 4 cases with liver cancer and 2 cases with portal thrombosis in group 3 were excluded because liver cancer and portal thrombosis could increase the rebleeding rate.
Rate of systemic embolism/case (%)	2 (9.09)	0 (0.00)	0 (0.00)	4.767	0.092
Survival rate/case (%)	20 (90.91)	30 (100.00)	20 (95.24)	2.694	0.260
Rate of post-therapeutic thrombosis/case (%)	2 (9.09)	1 (3.33)	3 (14.29)	1.966	0.369
Rate of rebleeding/case (%)*	9 (40.91)	9 (31.03)	4 (26.67)	0.251	0.618
Volume of cyanoacrylate at first time therapy/mL, median (P25, P75)	2.75 (1.50, 4.13)	4.00 (2.75, 4.50)	3.00 (3.00, 5.00)	4.046	0.132
Volume of lauromacrogol atfirst time therapy/mL, median (P25, P75)	12.50 (0.00, 20.00)	10.00 (10.00, 20.00)	10.00 (10.00, 10.00)	1.564	0.457
Clip number (median [P25, P75])	0.00 (0.00, 0.00)	2.00 (2.00, 3.00)	2.00 (1.00, 2.00)	49.36	0.000
Volume of cyanoacrylate in one year/mL, median (P25, P75)	4.75 (3.00, 8.00)	4.50 (3.00, 7.00)	5.00 (3.00, 7.25)	0.734	0.693
Volume of lauromacrogol in one year/mL, median (P25, P75)	20.00 (10.00, 46.63)	10.00 (10.00, 20.00)	20.00 (10.00, 50.00)	5.250	0.072
Therapeutic times in one year (median [P25, P75])	3.50 (2.00, 5.25)	3.00 (2.00, 4.00)	2.00 (2.00, 2.50)	7.527	0.023